Early Vascular Aging (EVA): New Directions in Cardiovascular Protection brings together the last decade of research related to the characterization of EVA, as well as the predictive power of pulse wave velocity (PWV). The book presents a novel approach to the problem of cardiovascular disease, showing it in relation to great vessels disease and revealing a comprehensive approach to the problem of increased rigidity of the great vessels, its causes, and further consequences. Information provided is accompanied by online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures. - Introduces the latest information on early vascular aging (EVA), complete with summaries of recent evidence and guidelines for relevant risk factor control- Ideal reference for the study of vascular aging, pulse wave velocity, arteriosclerosis, EVA, arterial stiffness, vascular, PWV biomarkers, and cardiovascular disease- Contains all the relevant information available from different fields of knowledge (from basic biology to epidemiology) in regard to EVA- Provides evidence that leads to a new target for interventions, early vascular aging (EVA) in subjects with early onset increased arterial stiffness- Includes online access to a supplemental website with video clips of anatomic specimens, cardiac imaging, and surgical procedures
List of Contributors
Enrico Agabiti-Rosei, Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
Tine de Backer
Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium
Cardiovascular Center, University Hospital Ghent, Ghent, Belgium
Luc van Bortel, Heymans Institute of Pharmacology, Ghent University, Ghent, Belgium
Pierre Boutouyrie
Department of Pharmacology, Hôpital Européen Georges Pompidou – Assistance Publique Hôpitaux de Paris, Paris, France
Institut National de la Santé et de la Recherche Médicale—INSERM U970, Paris, France
Université Paris-Descartes, Paris, France
Michel Burnier, Service of Nephrology and Hypertension, University Hospital, Lausanne, Switzerland
Mark Caulfield, William Harvey Research Institute, NIHR Biomedical Research Unit in Cardiovascular Disease at Barts Queen Mary University of London, UK
Pascal Challande, Université Pierre et Marie Curie, CNRS—UMR 7190, Paris, France
Pedro G. Cunha
Center for the Research and Treatment of Arterial Hypertension and Cardiovascular Risk, Internal Medicine Department, Guimarães—Centro Hospitalar do Alto Ave/Minho University, Guimarães, Portugal
Life and Health Science Research Institute (ICVS), School of Health Science, University of Minho, Braga, Portugal
ICVS/3B’s—PT Government Associate Laboratory, Braga/Guimarães, Portugal
Stephanie Debette
Department of Neurology, University Hospital of Bordeaux, and Center for Epidemiology and Public Health—INSERM U897, University of Bordeaux, France
Department of Neurology, Boston University School of Medicine, Boston, MA, USA
Andreas Edsfeldt
Experimental Cardiovascular Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden
Department of Cardiology, University Hospital of Skåne, Malmö/Lund, Sweden
Isabel Ferreira
Department of Clinical Epidemiology and Medical Technology Assessment, and CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands
School of Public Health, University of Queensland, Brisbane, Australia
Stanley S. Franklin, Heart Disease Prevention Program, Division of Cardiology, University of California, Irvine, CA, USA
Frej Fyhrquist, Minerva Institute, Helsinki, Finland
Panagiotis I. Georgianos, Section of Nephrology and Hypertension, 1st Department of Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Isabel Gonçalves
Experimental Cardiovascular Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden
Department of Cardiology, University Hospital of Skåne, Malmö/Lund, Sweden
Dagmara Hering, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland
Jens Jordan, Institute of Clinical Pharmacology, Medical School Hannover, Hannover, Germany
Vasilios Kotsis, Hypertension Centre of Excellence, 3rd Department of Internal Medicine, Papageorgiou Hospital, Aristotle University Thessaloniki, Thessaloniki, Greece
Michaela Kozakova, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
Roel J. van de Laar, Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands
Patrick Lacolley
Institut National de la Santé et de la Recherche Médicale—INSERM U116
Université de Lorraine, Nancy, France
Jérémy Lagrange
Institut National de la Santé et de la Recherche Médicale—INSERM U116
Université de Lorraine, Nancy, France
Edward G. Lakatta, Laboratory of Cardiovascular Science, Intramural Research Program, Biomedical Research Center, National Institute on Aging, NIH, Baltimore, MD, USA
Irene Lambrinoudaki, Medical School, University of Athens, Athens, Greece
Stéphane Laurent
Department of Pharmacology, Hôpital Européen Georges Pompidou – Assistance Publique Hôpitaux de Paris, Paris, France
Université Paris-Descartes, Paris, France
Institut National de la Santé et de la Recherche Médicale—INSERM U970, Paris, France
Yimin Lu, Service of Nephrology and Hypertension, University Hospital, Lausanne, Switzerland
Carmel M. McEniery, Department Experimental Medicine and Immunotherapeutics, University of Cambridge, Cambridge, UK
Krzysztof Narkiewicz, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland
Jan Nilsson, Experimental Cardiovascular Research Unit, Department of Clinical Sciences, Lund University, Malmö, Sweden
Peter M. Nilsson, Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden
Juan E. Ochoa, Department of Cardiovascular Neural and Metabolic Sciences, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy
Michael H. Olsen
Cardiovascular and Metabolic Preventive Clinic, Department of Endocrinology, Center for Individualized Medicine in Arterial Diseases, Odense University Hospital, Odense, Denmark
Hypertension in Africa Research Team, School for Physiology, Nutrition and Consumer Sciences, North-West University,Potchefstroom, South Africa
Carl J. Östgren, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
Carlo Palombo, Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy
Gianfranco Parati
Department of Health Sciences, University of Milano-Bicocca, Milan, Italy
Department of Cardiovascular Neural and Metabolic Sciences, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy
Veronique Regnault
Institut National de la Santé et de la Recherche Médicale—INSERM U116
Université de Lorraine, Nancy, France
Meixia Ren, William Harvey Research Institute, Centre for Clinical Pharmacology, Queen Mary University of London, UK
Ernst Rietzschel
Departments of Cardiovascular Diseases & Public Health, Ghent University, Ghent, Belgium
Department of Cardiology, Ghent University Hospital, Ghent, Belgium
Damiano Rizzoni, Clinica Medica, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
Paolo Salvi, Department of Cardiovascular Neural and Metabolic Sciences, S. Luca Hospital, IRCCS Istituto Auxologico Italiano, Milan, Italy
Pantelis A. Sarafidis, Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
Giuseppe Schillaci
Department of Medicine, University of Perugia, Perugia, Italy
Unit of Internal Medicine, Terni University Hospital, Terni, Italy
Arno Schmidt-Truksäss, Department of Sport, Exercise and Health, Sport and Exercise Medicine, University of Basel, Basel, Switzerland
Angelo Scuteri, Hospital San Raffaele Pisana, Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy
Patrick Segers, IBiTech-bioMMeda, iMinds Medical IT, Ghent University, Gent, Belgium
Thomas Sehestedt, Department of Cardiology, Herlev...
Erscheint lt. Verlag | 6.8.2015 |
---|---|
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Geriatrie |
Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie | |
Studium ► 1. Studienabschnitt (Vorklinik) ► Physiologie | |
ISBN-10 | 0-12-801676-0 / 0128016760 |
ISBN-13 | 978-0-12-801676-3 / 9780128016763 |
Haben Sie eine Frage zum Produkt? |
Größe: 16,9 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
Größe: 11,2 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich